220 related articles for article (PubMed ID: 11509924)
1. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Sun YP; Zhu BQ; Browne AE; Pulukurthy S; Chou TM; Sudhir K; Glantz SA; Deedwania PC; Chatterjee K; Parmley WW
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):175-81. PubMed ID: 11509924
[TBL] [Abstract][Full Text] [Related]
2. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function.
Wilmink HW; Banga JD; Hijmering M; Erkelens WD; Stroes ES; Rabelink TJ
J Am Coll Cardiol; 1999 Jul; 34(1):140-5. PubMed ID: 10400003
[TBL] [Abstract][Full Text] [Related]
4. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
5. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
Int J Mol Med; 2000 Nov; 6(5):591-4. PubMed ID: 11029530
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of ACE inhibition on coronary endothelial dysfunction.
Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Zhu BQ; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Grossman W; Karliner JS; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):31-7. PubMed ID: 12692751
[TBL] [Abstract][Full Text] [Related]
8. Chronic effects of ACE-inhibition (quinapril) and angiotensin-II-type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction.
Hu K; Bahner U; Gaudron P; Palkovits M; Ring M; Fehle A; Kruse B; Ertl G
Basic Res Cardiol; 2001; 96(3):258-66. PubMed ID: 11403419
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure.
Kawai H; Stevens SY; Liang CS
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3012-9. PubMed ID: 11087259
[TBL] [Abstract][Full Text] [Related]
10. BANFF: an update.
Anderson T
Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
[TBL] [Abstract][Full Text] [Related]
11. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
12. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
13. Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities.
Nakagawa H; Daihara M; Tamakawa H; Nozue T; Kawahara K
J Cardiovasc Pharmacol; 1999 Jul; 34(1):28-33. PubMed ID: 10413063
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of arterial thrombogenesis by quinapril but not losartan.
Bavry AA; Li D; Zander DS; Phillips MI; Mehta JL
J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):121-7. PubMed ID: 11150391
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of ACE inhibitors versus AT1 blockers.
Vaughan D
Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Teisman AC; Pinto YM; Buikema H; Flesch M; Böhm M; Paul M; van Gilst WH
J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study.
Lim SC; Koh AF; Goh SK; Chua CL; Heng BL; Subramaniam T; Sum CF
Diabetes Obes Metab; 2007 Jul; 9(4):477-82. PubMed ID: 17587389
[TBL] [Abstract][Full Text] [Related]
18. Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
Bastien NR; Juneau AV; Ouellette J; Lambert C
Cardiovasc Res; 1999 Jul; 43(1):77-85. PubMed ID: 10536692
[TBL] [Abstract][Full Text] [Related]
19. The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits.
Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):37-42. PubMed ID: 11881065
[TBL] [Abstract][Full Text] [Related]
20. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
